Joy Odili

1.0k total citations
17 papers, 471 citations indexed

About

Joy Odili is a scholar working on Biotechnology, Epidemiology and Molecular Biology. According to data from OpenAlex, Joy Odili has authored 17 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biotechnology, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Joy Odili's work include Microbial Inactivation Methods (13 papers), Nonmelanoma Skin Cancer Studies (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Joy Odili is often cited by papers focused on Microbial Inactivation Methods (13 papers), Nonmelanoma Skin Cancer Studies (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Joy Odili collaborates with scholars based in United Kingdom, Italy and Germany. Joy Odili's co-authors include Christian Kunte, P. Curatolo, Pietro Quaglino, Julie Gehl, Tobian Muir, L Campana, Giulia Bertino, Louise Wichmann Matthiessen, A. James P. Clover and Gregor Serša and has published in prestigious journals such as Annals of Oncology, Cancers and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

Joy Odili

15 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joy Odili United Kingdom 9 358 157 126 95 77 17 471
Aleš Grošelj Slovenia 13 388 1.1× 162 1.0× 165 1.3× 92 1.0× 114 1.5× 30 574
Roberta Rotunno Italy 11 263 0.7× 91 0.6× 123 1.0× 85 0.9× 70 0.9× 33 431
Louise Wichmann Matthiessen Denmark 7 467 1.3× 219 1.4× 184 1.5× 80 0.8× 89 1.2× 9 559
Erika Kis Hungary 12 210 0.6× 72 0.5× 97 0.8× 80 0.8× 92 1.2× 34 381
Michela Basso Italy 7 232 0.6× 136 0.9× 100 0.8× 59 0.6× 49 0.6× 8 347
Víctor Farricha Portugal 4 232 0.6× 117 0.7× 70 0.6× 51 0.5× 41 0.5× 8 290
Federica Marenco Italy 11 180 0.5× 72 0.5× 173 1.4× 189 2.0× 132 1.7× 15 505
Reintgen Ds United States 8 328 0.9× 227 1.4× 149 1.2× 166 1.7× 103 1.3× 9 526
Maksimiljan Kadivec Slovenia 6 150 0.4× 115 0.7× 47 0.4× 59 0.6× 36 0.5× 9 334
C. Calvet France 8 230 0.6× 173 1.1× 121 1.0× 184 1.9× 149 1.9× 18 528

Countries citing papers authored by Joy Odili

Since Specialization
Citations

This map shows the geographic impact of Joy Odili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Odili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Odili more than expected).

Fields of papers citing papers by Joy Odili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Odili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Odili. The network helps show where Joy Odili may publish in the future.

Co-authorship network of co-authors of Joy Odili

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Odili. A scholar is included among the top collaborators of Joy Odili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Odili. Joy Odili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Grošelj, Aleš, Giulia Bertino, Erika Kis, et al.. (2025). Electrochemotherapy for basal cell carcinoma in the head and neck region: 5-year follow-up from the Insp-ECT registry. Radiology and Oncology. 59(2). 233–243.
2.
Mascherini, Matteo, Alastair D. MacKenzie Ross, Barbara Silvestri, et al.. (2023). Efficacy of Electrochemotherapy in Breast Cancer Patients of Different Receptor Status: The INSPECT Experience. Cancers. 15(12). 3116–3116. 5 indexed citations
3.
Muir, Tobian, Giulia Bertino, Aleš Grošelj, et al.. (2023). Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report. Radiology and Oncology. 57(2). 141–149. 22 indexed citations
4.
Odili, Joy, et al.. (2022). The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high-risk basal cell carcinoma. Clinical and Experimental Dermatology. 47(11). 1995–1997. 2 indexed citations
5.
Campana, L, Pietro Quaglino, Francesca de Terlizzi, et al.. (2022). Health‐related quality of life trajectories in melanoma patients after electrochemotherapy: real‐world insights from the InspECT register. Journal of the European Academy of Dermatology and Venereology. 36(12). 2352–2363. 8 indexed citations
6.
Bertino, Giulia, Tobian Muir, Joy Odili, et al.. (2022). Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019). Current Oncology. 29(8). 5324–5337. 16 indexed citations
7.
Serša, Gregor, Matteo Mascherini, Joy Odili, et al.. (2021). Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: a matched cohort analysis from the InspECT registry. European Journal of Surgical Oncology. 47(2). e10–e10. 1 indexed citations
8.
Clover, A. James P., Giulia Bertino, P. Curatolo, et al.. (2019). Electrochemotherapy in the treatment of cutaneous malignancy; outcomes and subgroup analysis from the cumulative results from the pan- European InspECT Database for 1478 lesions in 691 patients (2008-2018). European Journal of Surgical Oncology. 45(2). e19–e19. 5 indexed citations
9.
Matthiessen, Louise Wichmann, Mohammed Keshtgar, P. Curatolo, et al.. (2018). Electrochemotherapy for Breast Cancer—Results From the INSPECT Database. Clinical Breast Cancer. 18(5). e909–e917. 32 indexed citations
10.
Gehl, Julie, Gregor Serša, Louise Wichmann Matthiessen, et al.. (2018). Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncologica. 57(7). 874–882. 269 indexed citations
11.
Ward, Joseph N. & Joy Odili. (2018). Dermatofibrosarcoma protuberans (DFSP) arising from a keloid scar – A case report. JPRAS Open. 18. 65–69. 3 indexed citations
12.
Rotunno, Roberta, Francesca de Terlizzi, Simone Ribero, et al.. (2017). Prospective pilot study evaluating the effectiveness of electrochemotherapy using reduced dosages of intravenous bleomycin. Journal of the European Academy of Dermatology and Venereology. 36–37. 1 indexed citations
13.
Rotunno, Roberta, L Campana, Pietro Quaglino, et al.. (2017). Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry. Journal of the European Academy of Dermatology and Venereology. 32(7). 1147–1154. 37 indexed citations
14.
Dunne, Jonathan, Justin C.R. Wormald, Jessica Steele, et al.. (2016). Is sentinel lymph node biopsy warranted for desmoplastic melanoma? A systematic review. Journal of Plastic Reconstructive & Aesthetic Surgery. 70(2). 274–280. 23 indexed citations
15.
Kunte, Christian, E.‐M. Grischke, Joy Odili, et al.. (2016). Electrochemotherapy for breast cancer - results from the INSPECT database. Annals of Oncology. 27. vi86–vi86. 2 indexed citations
16.
Quaglino, Pietro, Louise Wichmann Matthiessen, P. Curatolo, et al.. (2015). Predicting patients at risk for pain associated with electrochemotherapy. Acta Oncologica. 54(3). 298–306. 37 indexed citations
17.
Odili, Joy, et al.. (2012). Late infection of an alloplastic chin implant masquerading as squamous cell carcinoma. Journal of Plastic Reconstructive & Aesthetic Surgery. 65(6). e151–e152. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleš Grošelj Breakdown of academic impact, for papers by Roberta Rotunno Breakdown of academic impact, for papers by Louise Wichmann Matthiessen Breakdown of academic impact, for papers by Erika Kis Breakdown of academic impact, for papers by Michela Basso Breakdown of academic impact, for papers by Víctor Farricha Breakdown of academic impact, for papers by Federica Marenco Breakdown of academic impact, for papers by Reintgen Ds Breakdown of academic impact, for papers by Maksimiljan Kadivec Breakdown of academic impact, for papers by C. Calvet
Rankless by CCL
2026